focus -WSS

focus

author：explore 2025-09-27 23:00:32 - browse：1892

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Color Health wants to make cancer screenings convenient

hotspot

WSS

Travel bans should be based on evidence, not politics or fear

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

Germany receives 178 compensation applications from gay servicepeople over discrimination

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Study fuels hope CAR

STAT Madness 2024: Meet the contenders

knowledge

focus

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Children’s Hospital revives plan for pedestrian bridge

Supreme Court strikes down use of affirmative action

'Vaccine

As demand for Covid shots wanes, Moderna seeks its next success

Using force crossed my mind when examining a defiant young patient

Medical leaders decry Supreme Court decision on affirmative action

Wegovy cuts risk of cardiovascular events by 20%, study finds

Hepatitis C has a cure — but many Americans still lack access to it

Hospitals use virtual reality to design more inclusive rooms for kids

hotspot

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

More regulation could be coming for drug ads

Are embryos people? Reproductive medicine's future depends on the answer

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

More regulation could be coming for drug ads

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

focus

focus

hotspot

explore